17 अक्टूबर 2026
FDA PDUFA target action date for phentolamine ophthalmic solution 0.75%, a NDA from Opus Genetics and Viatris. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA PDUFA निर्णय तारीखें कैलेंडर